IL1β: In a recent study, using single-cell RNA sequencing data from various breast cancer subtypes (ER+/PR+, HER2+, and TNBC), the study identified that IL1β is significantly upregulated in triple-negative breast cancer (TNBC) samples. Here, IL1B is linked to triple-negative breast carcinoma.